The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
The Australian Regulatory Guidelines for Prescription Medicines (ARGPM), guidance on "Stability testing for prescription medicines", recommends to predict the shelf life of chemically derived medicines from stability data by taking the worst case situation at batch release into account. Consequently, if a change over time is observed, a release limit needs to be specified. Finding a release limit and the associated shelf life is supported, as well as the standard approach that is recommended by guidance Q1E "Evaluation of stability data" from the International Council for Harmonisation (ICH).
| Version: | 0.1.6 |
| Depends: | R (≥ 4.0) |
| Imports: | ggplot2, rlang, lifecycle |
| Suggests: | testthat |
| Published: | 2024-03-25 |
| DOI: | 10.32614/CRAN.package.expirest |
| Author: | Pius Dahinden [aut, cre], Tillotts Pharma AG [cph, fnd] |
| Maintainer: | Pius Dahinden <pius.dahinden at tillotts.com> |
| BugReports: | https://github.com/piusdahinden/expirest/issues |
| License: | GPL-2 | GPL-3 [expanded from: GPL (≥ 2)] |
| URL: | https://github.com/piusdahinden/expirest |
| NeedsCompilation: | no |
| Language: | en-GB |
| Materials: | README NEWS |
| CRAN checks: | expirest results |
| Reference manual: | expirest.pdf |
| Package source: | expirest_0.1.6.tar.gz |
| Windows binaries: | r-devel: expirest_0.1.6.zip, r-release: expirest_0.1.6.zip, r-oldrel: expirest_0.1.6.zip |
| macOS binaries: | r-release (arm64): expirest_0.1.6.tgz, r-oldrel (arm64): expirest_0.1.6.tgz, r-release (x86_64): expirest_0.1.6.tgz, r-oldrel (x86_64): expirest_0.1.6.tgz |
| Old sources: | expirest archive |
Please use the canonical form https://CRAN.R-project.org/package=expirest to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.